PARIS & SAN JOSE, Calif.--(BUSINESS WIRE)--LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of ...

PARIS--(BUSINESS WIRE)--LimFlow SA today announced enrollment of the first patient in the U.S. feasibility study of the LimFlow Percutaneous Deep Vein Arterialization (pDVA) System, a novel, purely ...

PARIS, July 28, 2021 /PRNewswire/ -- Today, LimFlow SA, the pioneer in developing minimally-invasive technology to treat chronic limb-threatening ischemia (CLTI), announced remarkable health economic ...

PARIS & SAN JOSE, Calif.--(BUSINESS WIRE)-- LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of ...

IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from ...

Just weeks after securing U.S. FDA approval for its flagship system to treat chronic limb-threatening ischemia (CLTI), Limflow SA kept the good news flowing to investors with the announcement of an ...

Cynthia Elford loves to travel and hike, but a few years ago, her Type 1 diabetes made getting around nearly impossible. By 2018, the Pennsylvania grandmother faced the possibility of losing her right ...

The first ever LimFlow procedure in the Western United States, was performed at Heart Hospital of New Mexico at Lovelace Medical Center by New Mexico Heart Institute vascular surgeons, Steven Henao ...

LimFlow has raised $33.5 million to take its treatment for critical limb ischemia (CLI) through a pivotal trial. The device diverts blood around severely diseased arteries, potentially saving the ...

IRVINE, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and ...